Postirradiation hyperthermia selectively potentiates the merocyanine 540-sensitized photoinactivation of small cell lung cancer cells

Photochemistry and Photobiology

Volumn 73, Issue 2, 2001, Pages 191-198

  Tsujino, Ichiro ^a   Anderson, Gregory S ^a   Sieber, Fritz ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MEROCYANINE;

ARTICLE; CANCER CELL CULTURE; CELL TYPE; CONTROLLED STUDY; DRUG EFFECT; GRANULOCYTE; HUMAN; HUMAN CELL; HYPERTHERMIA; IRRADIATION; LUNG SMALL CELL CANCER; MACROPHAGE; PHOTOCHEMISTRY; PRECURSOR CELL; SOLID TUMOR; STEM CELL TRANSPLANTATION; WILD TYPE;

BONE MARROW PURGING; CARCINOMA, SMALL CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYPERTHERMIA, INDUCED; LUNG NEOPLASMS; PHOTOSENSITIZING AGENTS; PYRIMIDINONES; TRANSPLANTATION, AUTOLOGOUS; TUMOR CELLS, CULTURED;

EID: 0035263175     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/0031-8655(2001)073<0191:PHSPTM>2.0.CO;2     Document Type: Article

References (90)

1. American Cancer Society(2000) Cancer Facts & Figures 2000. American Cancer Society, Atlanta.
2. Farha, P., G. Spitzer, M. Valdivieso, K. A. Dicke, A. Zander, H. M. Dhingra, G. Minnhaar, L. Vellekoop, D. S. Verma, T. Umsawasdi and D. Chiuten (1983) High-dose chemotherapy and autologous bone marrow transplantation for the treatment of small cell lung carcinoma. Cancer 52, 1351-1355.
3. Sculier, J. P., J. Klastersky and P. Stryckmans (1985) Late intensification in small-cell lung cancer: a phase I study of high doses of cyclophosphamide and etoposide with autologous bone marrow transplantation. J. Clin. Oncol. 3, 184-191.
4. Humblet, Y., M. Syman, A. Bosley, L. Delaunois, C. Francis, J. Machiels, M. Beauduin, C. Doyen, P. Weynants, J. Longueville and J. Prignot (1987) Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study. J. Clin. Oncol. 5, 1864-1873.
5. Marangolo, M., G. Rosti, D. Amadori, M. Leoni, A. Ardizzone, G. Fiorentini, G. Cruciani, A. Tienghi, A. Ravaioli, L. Sebastiani, D. Turci, T. Cotignoli, M. Argnani, E. Flamini and R. Rosso (1989) High-dose etoposide and autologous bone marrow transplantation as intensification treatment in small cell lung cancer: a pilot study. Bone Marrow Transplant. 4, 405-408.
6. Souhami, R. L., H. T. Hajichristou, D. W. Miles, H. M. Earl, P. G. Harper, C. M. Ash, A. H. Goldstone, S. G. Spiro, D. M. Geddes and J. S. Tobias (1989) Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancer. Cancer Chemother. Pharmacol. 24, 321-325.
7. Nomura, F., K. Shimokata, H. Saito, A. Watanabe, H. Saka, S. Sakai, Y. Kodera and H. Saito (1990) High dose chemotherapy with autologous bone marrow transplantation for limited small cell lung cancer. Jpn J. Clin. Oncol. 20, 94-98.
8. Rushing, D. A., W. R. Friedenberg, M. C. Baldauf, S. Broste, J. A. Gehlsen, D. H. Kriesel, D. P. Koontz and K. A. Rodvold (1991) High-dose carmustine and autologous bone marrow reinfusion in the treatment of refractory or relapsed small cell lung carcinoma. Cancer 68, 720-724.
9. Stiff, P. J., R. S. McKenzie, L. D. Potempa, K. Albain, D. Koch, E. Braud, V. K. Bansal, M. K. Weidner, V. J. Lanzotti, H. G. Chun, C. Johnson and R. I. Fisher (1991) A phase I trial of high-dose diaziquone and autologous bone marrow transplantation: an Illinois Cancer Council study. J. Clin. Oncol. 9, 1487-1494.
10. Lazarus, H. M. (1993) Autologous bone marrow transplantation for the treatment of lung cancer. Semin. Oncol. 20, 72-79.
11. Takahashi, M., H. Yoshizawa, H. Tanaka, J. Tanaka, H. Kagamu, K. Ito, T. Shimbo, D. Chou, M. Wakabayashi, E. Suzuki, K. Sakai, M. Arakawa and F. Gejyo (2000) A phase I dose escalation study of multicyclic, dose-intensive chemotherapy with peripheral blood stem cell support for small cell lung cancer. Bone Marrow Transplant. 25, 5-11.
12. Humblet, Y. and M. Syman (1988) Detection of small cell lung cancer bone marrow metastases by tumor stem cell assay. Pathol. Biol. 36, 83-85.
13. Brugger, W., K. J. Bross, M. Glatt, F. Weber, R. Mertelsmann and L. Kanz (1994) Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83, 636-640.
14. Brenner, M. (1998) Use of gene marking technologies in oncology. Forum 8, 342-353.
15. Fouillard, L., J. P. Laporte, M. Labopin, S. Lesage, F. Isnard, L. Douay, M. Lopez, M. Aoudjhane, P. Zunic, N. Cheron, J. Stachowiak, M. P. Lemonnier, G. Andreu, Y. Belkacemi, M. P. Noel-Walker, P. Morel, P. Fenaux, J. P. Jouet, F. Bauters, A. Najman and N. C. Gorin (1998) Autologous stem-cell transplantation for non-Hodgkin's lymphomas: the role of graft purging and radiotherapy post transplantation - results of a retrospective analysis on 120 patients autografted in a single institution. J. Clin. Oncol. 16, 2803-2816.
16. Gorin, N. C. (1998) Autologous stem cell transplantation in acute myelocytic leukemia. Blood 92, 1073-1090.
17. Matthay, K. K., J. G. Villablanca, R. C. Seeger, D. O. Stram, R. E. Harris, N. K. Ramsay, P. Swift, H. Shimada, C. T. Black, G. M. Brodeur, R. B. Gerbing and C. P. Reynolds (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. New Engl. J. Med. 341, 1165-1173.
18. Benard, J., L. Bettan-Renaud, A. Gavoille, J. L. Pico, F. Beaujean, M. Lopez and G. Riou (1988) In vitro chemical eradication of small cell lung cancer: application in autologous bone marrow transplantation. Eur. J. Cancer Clin. Oncol. 24, 1562-1566.
19. Humblet, Y., A. M. Feyens, M. Sekhavat, D. Agaliotis, J. L. Canon and M. L. Syman (1989) Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts. Cancer Res. 49, 5058-5061.
20. Meagher, R. C., S. A. Rothman, P. Paul, P. Koberna, C. Willmer and P. A. Baucco (1989) Purging of small cell lung cancer cells from human bone marrow using ethiofos (WR-2721) and light-activated merocyanine 540 phototreatment. Cancer Res. 49, 3637-3641.
21. Ball, E. D., F. J. Powers, J. J. Vredenburgh, C. A. Heath and A. O. Converse (1991) Purging of small cell lung cancer cells from bone marrow using immunomagnetic beads and a flow through device. Bone Marrow Transplant. 8, 35-40.
22. Myklebust, A. T., A. Pharo and O. Fodstad (1993) Effective removal of SCLC cells from human bone marrow. Use of four monoclonal antibodies and immunomagnetic beads. Br. J. Cancer 67, 1331-1336.
23. Margolin, K. A., C. Wright and S. J. Forman (1997) Autologous bone marrow purging by in situ IL-2 activation of endogenous killer cells. Leukemia 11, 723-728.
24. Sieber, F., R. C. Meagher and J. L. Spivak (1981) Differential sensitivity of mouse hematopoietic stem cells to merocyanine 540. Differentiation 19, 65-67.
25. Meagher, R. C., F. Sieber and J. L. Spivak (1983) Susceptibility to merocyanine 540-mediated photosensitization: a differentiation marker on murine hematopoietic progenitor cells. J. Cell. Physiol. 116, 118-124.
26. Sieber, F., J. L. Spivak and A. M. Sutcliffe (1984) Selective killing of leukemic cells by merocyanine 540-mediated photosensitization. Proc. Natl. Acad. Sci. USA 81, 7584-7587.
27. Atzpodien, J., S. C. Gulati and B. D. Clarkson (1986) Comparison of the cytotoxic effects of merocyanine-540 on leukemic cells and normal human bone marrow. Cancer Res. 46, 4892-4895.
28. Sieber, F., A. Craig, G. J. Krueger, R. E. Smith and R. C. Ash (1986) Autotransplantation of bone marrow after extracorporeal purging with merocyanine 540 and light. Blood 68, 292a.
29. Sieber, F., S. Rao, S. D. Rowley and M. Sieber-Blum (1986) Dye-mediated photolysis of human neuroblastoma cells: implications for autologous bone marrow transplantation. Blood 68, 32-36.
30. Sieber, F. and M. Sieber-Blum (1986) Dye-mediated photosensitization of murine neuroblastoma cells. Cancer Res. 46, 2072-2076.
31. Porcellini, A., N. Talevi, M. T. Marchetti-Rossi, M. Palazzi, A. Manna, G. Sparaventi, C. Delfini and M. Valentini (1987) Limiting dilution analysis for the determination of leukemic cell frequencies after bone marrow decontamination with mafosfamide or merocyanine 540. Blood 70, 1543-1549.
32. Sieber, F., R. K. Stuart, S. D. Rowley, S. J. Sharkis and L. L. Sensenbrenner (1987) Dye-mediated photolysis of normal and neoplastic hematopoietic cells. Leukemia Res. 11, 43-49.
33. Mumcuoglu, M., L. Weiss, J. Spivak and S. Slavin (1989) Differential killing of murine B-cell leukemia (BCL1) by photosensitiztion with merocyanine 540: implications for autologous bone marrow transplantation. Bone Marrow Transplant. 4, 143-146.
34. Sieber, F., G. J. Krueger, J. M. O'Brien, S. L. Schober, L. L. Sensenbrenner and S. J. Sharkis (1989) Inactivation of Friend erythroleukemia virus and Friend virus-transformed cells by merocyanine 540-mediated photosensitization. Blood 73, 345-350.
35. Sieber, F. (1990) Photosensitizing agents for marrow purging in autologous bone marrow transplantation. In Experimental Hematology Today - 1989 (Edited by N. C. Gorin and L. Douay), pp. 10-15. Springer, New York.
36. Sieber, F. (1991) Extracorporeal purging of bone marrow grafts by dye-sensitized photoirradiation. In Bone Marrow Processing and Purging: A Practical Guide (Edited by A. P. Gee), pp. 263-280. CRC Press, Boca Raton.
37. Itoh, T., H. A. Messner, N. Jamal, M. Tweeddale and F. Sieber (1993) Merocyanine 540-sensitized photoinactivation of high-grade non-Hodgkin's lymphoma cells: potential applications in autologous bone marrow transplantation. Bone Marrow Transplant. 12, 191-196.
38. Kasahara, K., Y. Fujiwara, K. Nishio, T. Ohmori, Y. Sugimoto, K. Komiya, T. Matsuda and N. Saijo (1991) Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res. 51, 3237-3242.
39. Anderson, G. S., W. H. H. Günther, R. Searle, J. M. Bilitz, M. Krieg and F. Sieber (1996) Inactivation of photosensitizing merocyanine dyes by plasma, serum and serum components. Photochem. Photobiol. 64, 683-687.
40. Valinsky, J. E., T. G. Easton and E. Reich (1978) Merocyanine 540 as a fluorescent probe of membranes: selective staining of leukemia and immature hematopoietic cells. Cell 13, 487-499.
41. Gaffney, D. K. and F. Sieber (1992) The role of serum and serum components in the merocyanine 540-sensitized photoinactivation of K562 leukemia cells. Biochim. Biophys. Acta 1117, 321-325.
42. Iscove, N. N., F. Sieber and K. H. Winterhalter (1974) Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A. J. Cell. Physiol. 83, 309-320.
43. Rogers, J., T. R. Hesketh, G. A. Smith, M. A. Beaven, J. C. Metcalfe, P. Johnson and P. B. Garland (1983) Intracellular pH and free calcium changes in single cells using quene 1 and quene 2 probes and fluorescence microscopy. FEBS Lett. 161, 21-27.
44. Rogers, J., T. R. Hesketh, G. A. Smith and J. C. Metcalfe (1983) Intracellular pH of stimulated thymocytes measured with a new fluorescent indicator. J. Biol. Chem. 258, 5994-5997.
45. Yamazaki, T., Y. Sato and F. Sieber (1997) Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts. Exp. Hematol. 25, 629-637.
46. Yamazaki, T. and F. Sieber (1997) Effect of hypothermia on the Merocyanine 540-mediated purging of hematopoietic cells. J. Hematother. 6, 31-49.
47. Traul, D. L., O. M. Smith and F. Sieber (1992) Effects of merocyanine 540-sensitized photoirradiation on cation homeostasis in L1210 leukemia and A549 lung carcinoma cells. Exp. Hematol. 20, 730.
48. Song, C. W., J. C. Lyons, R. J. Griffin, C. M. Makepeace and E. J. Gragoe, Jr. (1993) Increase in thermosensitivity of tumor cells by lowering intracellular pH. Cancer Res. 53, 1599-1601.
49. Liu, F.-F., K. Diep and R. P. Hill (1996) The relationship between thermosensitivity and intracellular pH in cells deficient in Na+/H+ antiport function. Radiother. Oncol. 40, 75-83.
50. Li, J.-H. and F.-F. Liu (1997) Intracellular pH and heat sensitivity in two human cancer cell lines. Radiother. Oncol. 42, 69-76.
51. Christensen, T., A. Wahl and L. Smedshammer (1984) Effects of haematoporphyrin derivative and light in combination with hyperthermia on cells in culture. Br. J. Cancer 50, 85-89.
52. Waldow, S., B. W. Henderson and T. J. Dougherty (1984) Enhanced tumor control following sequential treatments of photodynamic therapy (PDT) and localized microwave hyperthermia in vivo. Lasers Surg. Med. 4, 79-85.
53. Christensen, T., L. Smedshammer, A. Wahl and J. Moan (1985) Photodynamic effects and hyperthermia in vitro. Adv. Exp. Med. Biol. 193, 69-78.
54. Mang, T. S. and T. J. Dougherty (1985) Time and sequence dependent influence of in vitro photodynamic therapy (PDT) survival by hyperthermia. Photochem. Photobiol. 42, 533-540.
55. Henderson, B. W., S. M. Waldow, W. R. Potter and T. J. Dougherty (1985) Interaction of photodynamic therapy and hyperthermia: tumor response and cell survival studies after treatment of mice in vivo. Cancer Res. 45, 6071-6077.
56. Waldow, S. M., B. W. Henderson and T. J. Dougherty (1985) Potentiation of photodynamic therapy by heat: effect of sequence and time interval between treatments in vivo. Lasers Surg. Med. 5, 83-94.
57. Oseroff, A. R., D. Ohuoha and G. Ara (1987) Mild hyperthermia synergistically enhances killing of malignant cells by the cationic photosensitizer EDKC: implications for a "selective photohyperthermic therapy". In New Directions in Photodynamic Therapy, Vol. 847, (Edited by D. C. Neckers), pp. 11-14. SPIE, Bellingham, Proceedings of SPIE.
58. Levendag, P. C., H. P. Marijnissen, V. J. de Rue, J. A. Versteeg, G. C. van Rhoon and W. M. Star (1988) Interaction of interstitial photodynamic therapy and interstitial hyperthermia in a rat rhabdomyosarcoma - a pilot study. Int. J. Radiat. Oncol. Biol. Phys. 14, 139-145.
59. Miyoshi, N., N. Matsumoto, H. Hisazumi and M. Fukuda (1988) The effect of hyperthermia on murine leukaemia cells in combination with photodynamic therapy. Int. J. Hyperth. 4, 203-209.
60. Boegheim, J. P., J. W. Lagerberg, T. M. Dubbelman and J. Van Steveninck (1989) Damaging action of photodynamic treatment in combination with hyperthermia on transmembrane transport in murine L929 fibroblasts. Biochim. Biophys. Acta 979, 215-220.
61. Mang, T. S. (1990) Combination studies of hyperthermia induced by the neodymium:yttrium-aluminum-garnet (Nd:YAG) laser as an adjuvant to photodynamic therapy. Lasers Surg. Med. 10, 173-178.
62. Matsumoto, N., H. Saito, N. Miyoshi, K. Nakanishi and M. Fukuda (1990) Combination effect of hyperthermia and photodynamic therapy on carcinoma. Arch. Otolaryngol. Head Neck Surg. 116, 824-829.
63. Glassberg, E., L. Lewandowski, C. Halcin, G. Lask and J. Uitto (1991) Hyperthermia potentiates the effects of aluminum phthalocyanine tetrasulfonate-mediated photodynamic toxicity in human malignant and normal cell lines. Lasers Surg. Med. 11, 432-439.
64. 31p NMR study of combined hyperthermia and photodynamic therapies of mammary carcinoma in the mouse. Photochem. Photobiol. 54, 795-799.
65. Prinsze, C., T. M. Dubbelman and J. Van Steveninck (1991) Potentiation of thermal inactivation of glyceraldehyde-3-phosphate dehydrogenase by photodynamic treatment: a possible model for the synergistic interaction between photodynamic therapy and hyperthermia. Biochem. J. 276, 357-362.
66. Prinsze, C., K. Tijssen, T. M. Dubbelman and J. Van Steveninck (1991) Potentiation of hyperthermia-induced haemolysis of human erythrocytes by photodynamic treatment. Evidence for the involvement of the anion transporter in this synergistic interaction. Biochem. J. 277, 183-188.
67. Kimel, S., L. O. Svaasand, M. Hammer-Wilson, V. Gottfried, S. Cheng, E. Svaasand and M. W. Berns (1992) Demonstration of synergistic effects of hyperthermia and photodynamic therapy using the chick chorioallantoic membrane model. Lasers Surg. Med. 12, 432-440.
68. Prinsze, C., L. C. Penning, T. M. A. R. Dubbelman and J. Van Steveninck (1992) Interaction of photodynamic treatment and either hyperthermia or ionizing radiation and of ionizing radiation and hyperthermia with respect to cell killing of L929 fibroblasts, Chinese hamster ovary cells, and T24 human bladder carcinoma cells. Cancer Res. 52, 117-120.
69. Chen, Q., H. Chen, H. Shapiro and F. W. Hetzel (1996) Sequencing of combined hyperhermia and photodynamic therapy. Radiat. Res. 146, 293-297.
70. Rasch, M. H., K. Tijssen, J. Van Steveninck and T. M. Dubbelman (1996) Synergistic interaction of photodynamic treatment with the sensitizer aluminum phthalocyanine and hyperthermia on loss of clonogenicity of CHO cells. Photochem. Photobiol. 64, 586-593.
71. Busetti, A., M. Soncin, G. Jori, M. E. Kenney and M. A. Rodgers (1998) Treatment of malignant melanoma by high-peak-power 1064 nm irradiation followed by photodynamic therapy. Photochem. Photobiol. 68, 377-381.
72. Kelleher, D. K., O. Thews, J. Rzeznik, A. Scherz, Y. Salomon and P. Vaupel (1999) Water-filtered infrared-A radiation: a novel technique for localized hyperthermia in combination with bacteriochlorophyll-based photodynamic therapy. Int. J. Hyperth. 15, 467-474.
73. Orenstein, A., G. Kostenich, Y. Kopolovic, T. Babushkina and Z. Malik (1999) Enhancement of ALA-PDT damage by IR-induced hyperthermia on a colon carcinoma model. Photochem. Photobiol. 69, 703-707.
74. Rowley, S. D., M. Zuehlsdorf, H. G. Braine, O. M. Colvin, J. Davis, R. C. Jones, R. Saral, L. L. Sensenbrenner, A. Yeagher and G. W. Santos (1987) CFU-GM content of bone marrow grafts correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxy-cyclophosphamide-purged bone marrow. Blood 70, 272-275.
75. Kubo, Y. and F. Sieber (1997) Photochemical purging of autologous bone marrow grafts: assessment of damage to stem cells and the microenvironment in long-term marrow cultures. Bone Marrow Transplant. 20, 27-31.
76. Moriyama, Y., M. Narita, K. Sato, M. Urushiyama, S. Koyama, H. Hirosawa, K. Kishi, M. Takahashi, K. Takai and A. Shibata (1986) Application of hyperthermia to the treatment of human acute leukemia: purging human leukemic progenitor cells by heat. Blood 67, 802-804.
77. Moriyama, Y., K. Nikkuni, H. Saito, A. Aoki, T. Furukawa, A. Imanari, M. Narita, K. Kishi, M. Takahashi and A. Shibata (1990) In vitro sensitivity of human hematopoietic progenitor cells to hyperthermia: critical temperature for cells to survive and its application to in vitro purging. Bone Marrow Transplant. 6, 243-246.
78. Iwasawa, T., Y. Hirabayashi, N. Kubota, T. Inoue, M. Kakehi and K. Matsui (1991) Hyperthermic purging in vitro of murine leukemia cells (MK-8057): surviving fractions of normal and leukemic stem cells and the long-term survival of mice injected with post-hyperthermic leukemia cells. Exp. Hematol. 19, 332-337.
79. Wierenga, P. K. and A. W. Konings (1993) Studies on the hyperthermic sensitivity of the murine hematopoietic stem cell compartment. I. Heat effects on clonogenic stem cells and progenitors. Exp. Hematol. 21, 608-613.
80. Ingram, S. S., T. Samulski, R. Dodge, L. R. Prosnitz, P. Peters and J. Vredenburgh (1996) The effects of hyperthermia in bone marrow purging of breast cancer. Int. J. Hyperth. 12, 21-29.
81. Thijssen, S. F., J. W. van Oostveen, G. J. Schuurhuis, A. P. Theiijsmeijer, C. B. Oudejans, I. J. van Wijk, M. M. Langenhuijsen and G. J. Ossenkoppele (1997) Hypersensitivity of bcr-abl-positive progenitors to hyperthermia in patients with chronic myeloid leukemia. Leukemia 11, 1762-1768.
82. Herrmann, R. P., J. O'Reilley, B. F. Meyer and G. Lazzaro (1992) Prompt haematopoietic reconstitution following hyperthermia purged autologous marrow and peripheral blood stem cell transplantation in acute myeloid leukaemia. Bone Marrow Transplant. 10, 293-295.
83. Itoh, T., E. D. Ball and F. Sieber (1989) Antileukemic effect of merocyanine 540-mediated photosensitization combined with complement-mediated immune lysis and its role in the purging of autologous remission marrow grafts. In Bone Marrow Transplantation: Current Controversies (Edited by R. P. Gale and R. Champlin), pp. 301-312. Liss, New York.
84. 3 synergistically enhances the Merocyanine 540-mediated photoinactivation of leukemia cells: implications for the extracorporeal purging of autologous hematopoietic stem cells. Bone Marrow Transplant. 19, 113-119.
85. Sato, Y., J.-P. Daziano and F. Sieber (1998) Photochemical purging of autologous stem cell grafts: potentiation of the antileukemic activity of Merocyanine 540 by ethacrynic acid. Cancer Res. Ther. Contrib. 5, 241-251.
86. Okamoto, S., A. C. Olson, W. E. Berdel and W. R. Vogler (1988) Purging of acute myeloid leukemic cells by ether lipids and hyperthermia. Blood 72, 1777-1783.
87. Mansouri, A., C. J. Henle, A. M. Benson, A. J. Moss and W. A. Nagle (1989) Characterization of a cisplatin-resistant subline of murine RIF-1 cells and reversal of drug-resistance by hyperthermia. Cancer Res. 49, 2674-2678.
88. Gidali, J. and I. Feher (1992) The effect of combined purging with mafosfamide and hyperthermia on murine haematopoietic stem cells and leukaemogenic cells. Bone Marrow Transplant. 10, 479-483.
89. Osman, Y., Y. Moriyama and A. Shibata (1995) Enhanced elimination of Ph+ chromosome cells in vitro by combined hyperthermia and other drugs (AZT, IFN-alpha, TNF, and quercetin); its application to autologous bone marrow transplantation for CML. Exp. Hematol. 23, 444-452.
90. Wierenga, P. K., M. K. Brenner and A. W. Konings (1998) Enhanced selectivity of hyperthermic purging of human progenitor cells using Golaratide, an inhibitor of cell cycle progression. Bone Marrow Transplant. 21, 73-78.